These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11896613)

  • 1. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
    Dong Y; Asch HL; Ying A; Asch BB
    Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
    Itahana Y; Singh J; Sumida T; Coppe JP; Parrinello S; Bennington JL; Desprez PY
    Cancer Res; 2003 Nov; 63(21):7098-105. PubMed ID: 14612502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of the Id2 (inhibitor of differentiation) gene promoter during exit from the cell cycle.
    Biggs JR; Zhang Y; Murphy EV
    J Cell Physiol; 1995 Aug; 164(2):249-58. PubMed ID: 7622574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
    Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
    J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
    Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
    Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
    Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
    Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
    Huang YC; Hung WC
    J Cell Physiol; 2006 Nov; 209(2):363-9. PubMed ID: 16883603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.